- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on CNS in Sweden
Total 137 results
-
Karolinska InstitutetRecruitingMultiple SclerosisSweden
-
Karolinska InstitutetCompleted
-
GeNeuro Innovation SASCompleted
-
Karolinska InstitutetKarolinska University HospitalRecruitingMultiple Sclerosis | Postural BalanceSweden
-
Karolinska InstitutetThe Swedish Research Council; ForteCompletedMultiple SclerosisSweden
-
Karolinska InstitutetNeuro+CompletedMultiple Sclerosis | Fatigue | Cytokines | Resistance Training | Exercise TherapySweden
-
BayerBiogen Netherlands B.V; Novartis Europharm Limited; Merck Europe B.V.Not yet recruitingMultiple Sclerosis (MS)Sweden, Finland
-
Örebro County CouncilNorrbacka-Eugenia Foundation; Uppsala-Örebro Regional Research CouncilCompletedMultiple SclerosisSweden
-
University Hospital HeidelbergGerman Cancer Research CenterRecruitingSolid Tumor | CNS TumorFrance, Germany, Australia, Austria, Sweden, Netherlands, Switzerland
-
Jan LyckeCompletedMultiple Sclerosis, PharmacokineticsSweden
-
Karolinska InstitutetPatient-Centered Outcomes Research Institute; Kaiser Foundation Research InstituteActive, not recruitingRelapsing-remitting Multiple SclerosisSweden
-
Anders SvenningssonVästerbotten County Council, SwedenCompletedProgressive Multiple SclerosisSweden
-
Karolinska InstitutetKarolinska University HospitalRecruitingMultiple Sclerosis | Aging | Gait Disorders, Neurologic | Neuro-Degenerative DiseaseSweden
-
BiogenCompleted
-
BayerCompletedMultiple Sclerosis | Positron-Emission TomographyAustralia, Sweden
-
Karolinska InstitutetCompletedMultiple Sclerosis | Autologous Mesenchymal Stem CellsSweden
-
Otivio ASActive, not recruitingMultiple Sclerosis | Spasticity, Muscle | Pain, ChronicSweden
-
Örebro County CouncilNorrbacka-Eugenia Foundation; Uppsala-Örebro Regional Research CouncilCompleted
-
Uppsala UniversityNot yet recruitingMultiple Sclerosis | InsomniaSweden
-
University Hospital, LinkoepingCompletedFrailty | Frailty Syndrome | Emergency Department | Geriatric Assessment | CFSSweden
-
Uppsala UniversityKarolinska University Hospital; Sahlgrenska University Hospital, Sweden; University... and other collaboratorsCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingSweden
-
Exoneural Network ABNot yet recruitingStroke | Multiple Sclerosis | Cerebral Palsy | Spinal Cord Injuries | Neurologic DisorderSweden
-
Haukeland University HospitalRecruitingMultiple SclerosisNorway, Sweden, Denmark, Netherlands
-
BayerWithdrawnMultiple SclerosisSweden, Denmark
-
Umeå UniversityVästerbotten County Council, SwedenRecruitingStroke | Epilepsy | Multiple Sclerosis | Parkinson Disease | Brain Tumor | Traumatic Brain InjurySweden
-
Haukeland University HospitalOslo University Hospital; University Hospital of North Norway; Helse Stavanger... and other collaboratorsActive, not recruitingRelapsing Remitting Multiple SclerosisNorway, Sweden
-
Göteborg UniversityThe Swedish Research Council; Swedish Council for Working Life and Social ResearchCompletedStroke | Multiple Sclerosis | Parkinson Disease | Aphasia | AnomiaSweden
-
Tomas OlssonThe Swedish Research CouncilRecruiting
-
Anders SvenningssonCompletedMultiple Sclerosis, Relapsing-RemittingSweden
-
GlaxoSmithKlineCompletedMultiple SclerosisBelgium, Sweden, Czech Republic, Denmark, Norway
-
Karolinska InstitutetActive, not recruitingMultiple Sclerosis, Relapsing-RemittingSweden
-
EMD SeronoCompleted12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.Multiple SclerosisUnited States, Canada, Germany, Italy, Spain, Sweden
-
BayerCompletedMultiple SclerosisSwitzerland, Poland, France, Germany, Hungary, Spain, Sweden, Austria, Czech Republic, Italy, Slovenia, Israel, Belgium, Denmark, Netherlands, Canada, Norway, Finland
-
BiogenBiogen Idec A/SCompletedExerciseSweden, Finland, New Zealand, Denmark, Norway, Australia
-
Novartis PharmaceuticalsCompleted
-
Karolinska InstitutetThe Swedish Research CouncilCompletedPANDAS | Obsessive-compulsive Disorder | Obsessive-compulsive Disorder With Acute Onset | Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections | Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) | Childhood Acute Neuropsychiatric Symptoms (CANS)Sweden
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
BiogenRecruitingMultiple SclerosisUnited States
-
Bristol-Myers SquibbActive, not recruitingMultiple SclerosisUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis | Relapsing-RemittingSweden, Germany
-
Genzyme, a Sanofi CompanyTerminatedMultiple SclerosisUnited States, Australia, Austria, Belgium, Canada, Denmark, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom
-
Novartis PharmaceuticalsTerminatedMultiple SclerosisBelgium, Spain, Russian Federation, France, Italy, Poland, Sweden, Turkey, Czech Republic, Japan
-
AmgenRecruitingNeuromyelitis Optica Spectrum DisorderUnited Kingdom, United States, Sweden, Netherlands
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
-
Eli Lilly and CompanyBioMS Technology Corp.TerminatedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Latvia, Spain, Sweden, United Kingdom, Germany, Netherlands
-
BiogenCompletedMultiple SclerosisSweden, United Kingdom, Netherlands, Belgium, Canada, Italy
-
BayerCompletedMultiple SclerosisSwitzerland, France, Germany, Indonesia, Korea, Republic of, Spain, Sweden, Thailand, Taiwan, Australia, Austria, Colombia, Czech Republic, Italy, Jordan, Kazakhstan, Lebanon, Mexico, Slovenia, United Kingdom, Bahrain, Egypt, United... and more